What Is Neo? Chemoimmunotherapy in the Neoadjuvant Setting for Resectable Non–Small-Cell Lung Cancer | Journal of Clinical Oncology
![The effect of smoking status on efficacy of immune checkpoint inhibitors in metastatic non-small cell lung cancer: A systematic review and meta-analysis - eClinicalMedicine The effect of smoking status on efficacy of immune checkpoint inhibitors in metastatic non-small cell lung cancer: A systematic review and meta-analysis - eClinicalMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/f2e83ecf-937c-40a9-b087-40baf586dbd2/gr1.jpg)
The effect of smoking status on efficacy of immune checkpoint inhibitors in metastatic non-small cell lung cancer: A systematic review and meta-analysis - eClinicalMedicine
![Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer | Nature Communications Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-22801-0/MediaObjects/41467_2021_22801_Fig1_HTML.png)
Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer | Nature Communications
Highly Potent, Selective, Biostable, and Cell-Permeable Cyclic d-Peptide for Dual-Targeting Therapy of Lung Cancer | Journal of the American Chemical Society
![Real-world outcomes versus clinical trial results of immunotherapy in stage IV non-small cell lung cancer (NSCLC) in the Netherlands | Scientific Reports Real-world outcomes versus clinical trial results of immunotherapy in stage IV non-small cell lung cancer (NSCLC) in the Netherlands | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-85696-3/MediaObjects/41598_2021_85696_Fig1_HTML.png)
Real-world outcomes versus clinical trial results of immunotherapy in stage IV non-small cell lung cancer (NSCLC) in the Netherlands | Scientific Reports
![Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/c5ce84c4-2996-4e43-9e4d-5447ad0ccc66/gr1_lrg.jpg)
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
![A comparison of machine learning methods for predicting recurrence and death after curative-intent radiotherapy for non-small cell lung cancer: Development and validation of multivariable clinical prediction models - eBioMedicine A comparison of machine learning methods for predicting recurrence and death after curative-intent radiotherapy for non-small cell lung cancer: Development and validation of multivariable clinical prediction models - eBioMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/35cb93bf-2d1d-4e1b-a722-8272440d8ef1/gr1_lrg.jpg)